NCT01748942View on ClinicalTrials.gov

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

March 29, 2017

Conditions

DysphagiaPainStage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell Carcinoma

Interventions

DRUG

Dexamethasone

Given IV

DRUG

Dexamethasone

Given PO

OTHER

Placebo

Given PO

PROCEDURE

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Transoral Robotic Surgery

Undergo TORS

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT01748942 - Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter